Venture Capital Investors

ABL Bio

ABL Bio is focused on investing in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Venture Investor
ABL Bio
Status
Active
Investor Type
Venture Capital
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Sang Lee
Title
Chief Executive Officer
Mailing Address
456, Bongeunsa-ro, Gangnam-gu
Seoul, 06153
Republic of Korea
Email Address

Background Information

Overview
ABL Bio is a research-led biotechnology company, a pioneer in bispecific antibodies for immuno-oncology and neurodegenerative diseases. Delivering new approaches to address the highest unmet needs, we are committed to improving the lives of people all over the world.
Profile
ABL Bio LinkedIn Company Profile
Social Media
ABL Bio Company Twitter Account
Company News
ABL Bio News
Facebook
ABL Bio on Facebook
YouTube
ABL Bio on YouTube
Last Transaction
11/5/2025

Transaction History

Our records indicate that ABL Bio invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
11/5/2025
$75,000,000

 


Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Sang Lee
  Sang Lee LinkedIn Profile  Sang Lee Twitter Account  Sang Lee News  Sang Lee on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

ABL Bio has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Abingworth | Able Partners

 

Share this article

 


About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary